NCT06240546View on ClinicalTrials.gov

First-in-Human Study of LPM6690176 in Patients With Advanced Solid Tumors.

PHASE1RecruitingINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions

Advanced Solid Tumor

Interventions

DRUG

LPM6690176

Administered orally

Trial Locations (1)

Unknown

RECRUITING

Beijing Cancer Hospital, Beijing

All Listed Sponsors

lead

Luye Pharma Group Ltd.

INDUSTRY